TrialJournal of gastroenterology2019

Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.

Yuko Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.